View of Dual BRAF-EGFR Targeting by Lantadene and Peronemin Derivatives from Peronema canescens: A Molecular Docking and ADMET-Based Computational Study Against Drug-Resistant Non-Small Cell Lung Cancer (NSCLC)

Return to Article Details Dual BRAF-EGFR Targeting by Lantadene and Peronemin Derivatives from Peronema canescens: A Molecular Docking and ADMET-Based Computational Study Against Drug-Resistant Non-Small Cell Lung Cancer (NSCLC) Download Download PDF